Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation.
about
Role of Envelopment in the HEV Life CycleHepatitis E PathogenesisZoonotic Hepatitis E Virus: Classification, Animal Reservoirs and Transmission RoutesReview article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy.Advances in hepatitis E - I: virology, pathogenesis and diagnosis.Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice.Distinct Entry Mechanisms for Nonenveloped and Quasi-Enveloped Hepatitis E VirusesHumanized Mouse Models of Clinical Disease.Humanized mice: A brief overview on their diverse applications in biomedical research.Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice.Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity.Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection.[A murine model for an ignored chronic infection: hepatitis E !]Treatment of Hepatitis E.Animal Models for Hepatitis E Virus.Murine tissues of human liver chimeric mice are not susceptible to HEV of genotype 1 and 3.Hepatitis E virus: advances and challenges.Public health risks associated with hepatitis E virus (HEV) as a food‐borne pathogenTreatment of chronic hepatitis E with ribavirin: lessons from deep sequencing.The use of humanized mice for studies of viral pathogenesis and immunity.
P2860
Q26739943-F205CE31-2BFE-448B-8596-DC834BC45944Q26741395-C5954036-0091-42C9-9F2A-60DD6C97A896Q28070204-E02DD519-96B6-44EA-88AC-DBCCF206E722Q30234629-3365B422-9772-43F4-956B-6B988B2244AFQ30250366-8C2D4254-6A2A-4082-B5DA-7254D6039B9BQ33807794-27D7D826-2A07-49E0-A64E-B1A335586002Q36736370-134F61CD-51C7-4AB1-89E5-8C148E6E1E4AQ37614202-256A99AC-AE24-4705-982E-29F047F40CCAQ39329450-F2860424-B736-41A2-A6BF-FBAAC1E9457CQ40082002-4A30B74A-216A-4A49-BA61-86FECFEACE50Q40153625-10AE7471-9135-41EE-AE53-7CC1C3DB57CFQ40398599-0641EECE-DCC7-482A-9F64-0D459E3DA8FDQ40498720-1D378DFB-6C57-4276-86D0-46592A37635CQ40507403-1C780B7B-D312-4852-B746-980405359D68Q40507421-9C58D19B-8324-494B-86BE-07448CF4006BQ41926455-FB4D9B3C-F58C-470B-80C2-3B89666E14F6Q45324469-69E192A7-9943-4B59-8193-27765DC934B7Q47159881-C5FD43A8-C178-438E-A865-F6F82E007F2EQ50270854-4ABCCB22-96E2-4F67-BC7A-1346E53AFF03Q54244413-A2A2B14D-EE27-44FE-9D63-936CD7AAF61C
P2860
Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Human liver chimeric mice as a ...... d preclinical drug evaluation.
@en
type
label
Human liver chimeric mice as a ...... d preclinical drug evaluation.
@en
prefLabel
Human liver chimeric mice as a ...... d preclinical drug evaluation.
@en
P2093
P1476
Human liver chimeric mice as a ...... nd preclinical drug evaluation
@en
P2093
Anja Schöbel
Anne Groth
Ansgar W Lohse
Gianna Rapp
Janine Kah
Katja Giersch
Lena Allweiss
Marc Lütgehetmann
Maura Dandri
Sofia Gass
P304
P356
10.1016/J.JHEP.2016.01.011
P577
2016-01-22T00:00:00Z